Cargando…
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
The RHO family of RAS-related GTPases in tumors may be activated by reduced levels of RHO GTPase accelerating proteins (GAPs). One common mechanism is decreased expression of one or more members of the Deleted in Liver Cancer (DLC) family of Rho-GAPs, which comprises three closely related genes (DLC...
Autores principales: | Wang, Dunrui, Qian, Xiaolan, Rajaram, Megha, Durkin, Marian E., Lowy, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216712/ https://www.ncbi.nlm.nih.gov/pubmed/27174913 http://dx.doi.org/10.18632/oncotarget.9266 |
Ejemplares similares
-
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
por: Tripathi, Brajendra K., et al.
Publicado: (2019) -
The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
por: Sanchez-Solana, Beatriz, et al.
Publicado: (2021) -
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)